LYRA THERAPEUTICS INC
LYRA
LYRA was delisted on the 16th of March, 2026.
62 hedge funds and large institutions have $8.36M invested in LYRA THERAPEUTICS INC in 2024 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 13 increasing their positions, 13 reducing their positions, and 8 closing their positions.
138% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 8
22% more funds holding
Funds holding: 51 → 62 (+11)
0% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 13
0.08% less ownership
Funds ownership: 1.07% → 0.99% (-0.08%)
8% less capital invested
Capital invested by funds: $9.06M → $8.36M (-$698K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SEI Investments
Oaks,
Pennsylvania
|
+$293K |
| 2 |
Goldman Sachs
New York
|
+$154K |
| 3 |
EFG
Everhart Financial Group
Dublin,
Ohio
|
+$74.2K |
| 4 |
State Street
Boston,
Massachusetts
|
+$67.2K |
| 5 |
BlackRock
New York
|
+$48.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
-$286K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$257K |
| 3 |
New York State Common Retirement Fund
Albany,
New York
|
-$67K |
| 4 |
Two Sigma Advisers
New York
|
-$65K |
| 5 |
Two Sigma Investments
New York
|
-$61.2K |
LYRA Hedge Fund Activity: Q3 2024 in Review
62 of the 6,966 institutional investors tracked by Wall St. Rank reported a position in LYRA THERAPEUTICS INC (LYRA) for Q3 2024, worth a combined $8.36M — down 7.7% from $9.06M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new LYRA positions and 8 closed out — a net gain of 11 holders — while 13 added to existing stakes and 13 trimmed.
The largest buyer was SEI Investments, opening a new position worth an estimated $293K. The largest seller was Rosalind Advisors, exiting entirely with an estimated $286K sold.
- 62 institutional investors held LYRA THERAPEUTICS INC (LYRA) as of Q3 2024, up from 51 in Q2 2024.
- Funds reported $8.36M of LYRA THERAPEUTICS INC stock for Q3 2024, down 7.7% quarter-over-quarter.
- 19 funds opened new LYRA THERAPEUTICS INC positions in Q3 2024 and 8 closed out, a net change of +11 holders.
- The largest LYRA THERAPEUTICS INC buyer in Q3 2024 was SEI Investments, an estimated $293K added.
- The largest LYRA THERAPEUTICS INC seller in Q3 2024 was Rosalind Advisors, an estimated $286K sold.
Based on aggregated 13F filings for Q3 2024.